Stock CHGX CHITOGENX INC.
Add to a list
To use this feature you must be a member
Log inSign up

News ChitogenX Inc.

Equities

CHGX

CA1699161032

Market Closed - Canadian Securities Exchange
Other stock markets
 09:34:23 2024-04-19 am EDT 		5-day change 1st Jan Change
0.065 CAD +62.50% Intraday chart for ChitogenX Inc. +62.50% 0.00%
Feb. 28 Chitogenxinc. Announces Resignation of Philippe Deschamps from the Board of Directors CI
Feb. 28 Chitogenx Inc. Announces CEO Changes CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
CHITOGENX ANNOUNCES EXECUTIVE LEADERSHIP CHANGES
AQ
Chitogenxinc. Announces Resignation of Philippe Deschamps from the Board of Directors
CI
Chitogenx Inc. Announces CEO Changes
CI
CHITOGENX REPORTS THIRD QUARTER 2024 RESULTS
AQ
ChitogenX Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023
CI
CHITOGENX DEMONSTRATES ORTHO-R EFFICACY AND OSTEOARTHRITIS PROTECTION IN LARGE ANIMAL MENISCAL REPAIR STUDY
AQ
Chitogenx Inc. Demonstrates ORTHO-R Efficacy and Osteoarthritidevelopment in Large Animal Study
CI
ChitogenX Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023
CI
CHITOGENX REPORTS SECOND QUARTER 2024 RESULTS
AQ
ChitogenX Inc. Receives Notice of Allowance for Key Patent in United States and Canada
CI
CHITOGENX RECEIVES NOTICE OF ALLOWANCE FOR KEY PATENT IN UNITED STATES AND CANADA
AQ
ChitogenX Concluded Enrolment For Its U.S. Multi-site Rotator Cuff Tear Repair Phase I/II Clinical Trial
MT
CHITOGENX CONCLUDES ENROLMENT FOR ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL
AQ
Chitogenx Concludes Enrolment for Its U.S. Phase I/II Rotator Cuff Tear Repair Clinical Trial
CI
CHITOGENX ANNOUNCES VOTING RESULTS OF ITS ANNUAL GENERAL MEETING OF SHAREHOLDERS
AQ
CHITOGENX REPORTS FIRST QUARTER 2024 RESULTS
AQ
ChitogenX Reports Q1 Results
MT
CHITOGENX REPORTS FIRST QUARTER 2024 RESULTS
AQ
ChitogenX Inc. Reports Earnings Results for the First Quarter Ended April 30, 2023
CI
CHITOGENX RETAINS BRUDER CONSULTING AND VENTURE GROUP TO BROADEN AND ACCELERATE ONGOING STRATEGIC DEVELOPMENT PARTNERSHIP DISCUSSIONS
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CHGX Stock
  4. News ChitogenX Inc.